We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+22.89%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$357M
AUM Growth
+$3K
(+0%)
Cap. Flow
-$4.39M
Cap. Flow
% of AUM
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
68
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$4.39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.62% |
| 2 | Healthcare | 24.24% |
| 3 | Financials | 14.33% |
| 4 | Communication Services | 7.36% |
| 5 | Consumer Discretionary | 6.2% |
Similar funds
ECA
DWML
BOA
PLU
CPW
AWM
CAAM
SCP
De Burlo Group's Q2 2020 Portfolio in Review
As of Q2 2020, De Burlo Group held 68 positions worth $357M, up 0% from $357M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Trading was light in Q2 2020: portfolio turnover was 0%. De Burlo Group opened no new positions and made no exits, leaving the 68-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
- De Burlo Group's biggest Q2 2020 reduction was Edwards Lifesciences, cutting an estimated $4.39M.
- De Burlo Group's ten largest holdings make up 48% of its $357M portfolio in Q2 2020.
- De Burlo Group opened 0 new positions and closed 0 in Q2 2020.
- De Burlo Group's portfolio value rose 0% quarter-over-quarter to $357M.
Based on De Burlo Group's 13F filing for Q2 2020, filed 6 Aug 2020.